In our study, although the incidence of AKI was not statistically significant, patients with Hb*SpO2 < aaHb still exhibited a nominally higher incidence than those with Hb*SpO2 ≥ aaHb (19.8% vs. 14.0%, Table 5). The gene discussed is GSTM1; the disease is acute kidney injury.